The first cannabis drug, Epidiolex, created to treat rare forms of epilepsy could cost 32 500 dollars a year
Now that the Food and Drug Administration (FDA) has approved the first cannabis compound to treat two rare forms of childhood epilepsy. But no one can afford to buy it. The cost of Epidiolex is exorbitant, at 32 dollars per year ...
The cost of Epidiolex
Epidiolex, manufactured by the British company GW Pharmaceuticals, told investors that it would cost about 32 500 dollars per year.
Julian Gangolli, leads GW's marketing efforts in the United States. According to him, the price of Epidiolex is in line with other drugs for epilepsy. The price remains based on returns from insurance companies...
Gangolli said that the waiting time to receive the drug can be up to three weeks… Finally, after the patients have received a prescription…
However, before being able to write an Epidiolex prescription, the DEA must legislate on the CBD. Currently, the CBD is registered at the same time as marijuana as a drug of theannex 1. For the DEA, the CBD seems without "medical use accepted".
June 25, 2018, when Epidiolex was approved by the FDA. The agency had 90 days to re-classify it as a Schedule 2, 3, 4 or 5 substance.
“We have no choice,” said Barbara Carreno, public affairs manager at the DEA, in June. It hasn't happened yet.
Patients will be able to access Epidiolex with a prescription from a doctor, but how can they pay for it?
Researchers and advocates naturally warn against this. Due to the impossibility of knowing the content of these products and their sources.
Gangolli gave hope: with insurance, Epidiolex could be significantly cheaper than dispensary CBD.
"The cost of a coinsurance [for Epidiolex] is significantly - or could be considerably - lower and more expensive than the cost of the product on the Internet or in a dispensary," Gangolli said, according to Business Insider.